Sergliflozin etabonate
Sergliflozin etabonate (GW-869682X) is a potent and orally active sodium glucose cotransporter (SGLT2) inhibitor. Sergliflozin etabonate shows antidiabetic and antihyperglycemic effects. Sergliflozin etabonate significantly reduces non-fasting blood glucose levels in diabetic mice. Sergliflozin etabonate has the potential for the research of diabetes[1].
Product Specifications
CAS Number
[408504-26-7]
Product Name Alternative
GW-869682X
UNSPSC
12352005
Target
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sergliflozin-etabonate.html
Concentration
10mM
Purity
99.64
Solubility
DMSO : ≥ 100 mg/mL
Smiles
COC(C=C1)=CC=C1CC(C=CC=C2)=C2O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)COC(OCC)=O
Molecular Formula
C23H28O9
Molecular Weight
448.46
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT2
Available Sizes
Explore Other Products
Browse additional items from our catalog
C1QTNF1 (Complement C1q Tumor Necrosis Factor-related Protein 1, G-Protein-coupled Receptor-interacting Protein, GIP, CTRP1, UNQ310/PRO353, FLJ90694, ZSIG37) (PE)
C1QTNF1 (Complement C1q Tumor Necrosis Factor-related Protein 1, G-Protein-coupled Receptor-interacting Protein, GIP, CTRP1, UNQ310/PRO353, FLJ90694, ZSIG37) (PE)
Recombinant Shigella Sonnei mnmE Protein (aa 1-454)
